ArticleCancer communications (London, England)2025
Pan-cyclin-dependent kinase inhibition is a potential treatment for adenoid cystic carcinoma that downregulates the MYB::NFIB fusion and induces tumor regression.
Junchi Huang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.